• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

GE Vernova misses earnings, revenue estimates in Q4; stock down

by January 22, 2025
written by January 22, 2025

Investing.com — GE Vernova (NYSE:GEV) saw its shares slide more than 4% in premarket trading Wednesday after the company’s fourth-quarter results missed average analyst expectations.

The energy company posted Q$4 earnings per share (EPS) of $1.73, notably worse than the consensus estimate of $2.37. Revenue for the quarter came in at $10.56 billion, also below the consensus expectation of $10.7 billion.

GE Vernova generated power revenue of $5.43 billion, narrowly missing the forecast of $5.47 billion. Wind revenue was $3.11 billion, slightly exceeding the estimate of $3.09 billion, while Electrification revenue totaled $2.18 billion, surpassing the projected $2.14 billion.

Adjusted free cash flow for the quarter stood at $572 million, which was short of the $594.7 million expected by analysts.

“GE Vernova built a strong foundation in 2024 with solid orders and revenue growth, as well as significant margin expansion and cash generation. We saw strength in Power and Electrification and improvement in Wind, while growing our equipment backlog at better margins,” said GE Vernova CEO Scott Strazik.

“Our progress reinforces the important role we play in electrifying and decarbonizing the world as we deliver on accelerating demand for our equipment and services. As we enter 2025, I’m grateful for our team’s dedication and optimistic about the future as we continue creating value for our stakeholders.”

For full year 2025, GE Vernova anticipates revenue between $36 billion and $37 billion, close to the consensus estimate of $36.81 billion.

The company continues to project adjusted free cash flow of $2 billion to $2.5 billion, compared with the analyst estimates of $2.04 billion

It also maintained its outlook for a high-single-digit adjusted EBITDA margin for 2025.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Textron Q4 earnings and revenue miss, shares dip
next post
J&J tops earnings estimates amid strong demand for cancer treatments

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Netflix says its ad tier now has 94 million monthly active users

      May 15, 2025
    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

      May 15, 2025
    • YouTube will stream NFL Week 1 game in Brazil for free

      May 15, 2025
    • 5 new Uber features you should know — including a way to avoid surge pricing

      May 15, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (463)
    • Stock (6,426)

    Latest News

    • Netflix says its ad tier now has 94 million monthly active users
    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

    Popular News

    • Dollar sags to one-week low after safety bid, ‘Trump trade’ momentum wanes
    • Risk assets may be entering ‘danger zone’: McGeever

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy